Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
MacroGenics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MGNX
05:45am, Friday, 16'th Aug 2024
NEW YORK , Aug. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX) of a class action securities lawsuit. CLASS DEFI
Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors – Contact Levi & Korsinsky
08:45pm, Thursday, 15'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors - Contact Levi & Korsinsky
07:00pm, Thursday, 15'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
RADNOR, PA / ACCESSWIRE / August 15, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United Stat
Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors - Contact Levi & Korsinsky
02:45pm, Thursday, 15'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit – MGNX
09:30pm, Monday, 12'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Shareholders that lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX
08:00pm, Monday, 12'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc.(MGNX) Shareholders
07:15pm, Monday, 12'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Investors Have The Chance To Lead The Securities Fraud Lawsuit Against MacroGenics Inc With The Schall Law Firm
04:45pm, Monday, 12'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. ("MacroGenics
Shareholders That Lost Money on MacroGenics, Inc.(MGNX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
02:45pm, Monday, 12'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
September 24, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MGNX
10:45am, Monday, 12'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
MacroGenics (MGNX) Halts Prostate Cancer Trial After Fatal Adverse Events, Investor Suit – Hagens Berman
10:20am, Monday, 12'th Aug 2024
SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now.
The Gross Law Firm Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline
05:30am, Monday, 12'th Aug 2024
NEW YORK , Aug. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MacroGenics, Inc. (NASDAQ: MGNX). Shareholders who purchased shares of MGNX during the class
